CytoSorbents Corp (CTSO) - Product Pipeline Analysis, 2019 Update
August 2019
45
About the Report
About the Report
Summary
CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins. CytoSorbents' CytoSorb is also being administered during and after cardiac surgery to prevent post-operative complications such as multiple organ failure. The company offers VetResQ, a blood purification adsorber, to support and treat excessive inflammation and toxic injury in animals. The company offers its products through a network of distributors across Europe, the Middle East and Asia Pacific. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CytoSorbents Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
CytoSorbents Corp, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Aethlon Medical Inc
NxStage Medical Inc
Hologic Inc
HemoCleanse Technologies LLC
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
CytoSorbents Corp Company Overview
CytoSorbents Corp Company Snapshot
CytoSorbents Corp Pipeline Products and Ongoing Clinical Trials Overview
CytoSorbents Corp-Pipeline Analysis Overview
CytoSorbents Corp-Key Facts
CytoSorbents Corp-Major Products and Services
CytoSorbents Corp Pipeline Products by Development Stage
CytoSorbents Corp Ongoing Clinical Trials by Trial Status
CytoSorbents Corp Pipeline Products Overview
BetaSorb
BetaSorb Product Overview
ContrastSorb
ContrastSorb Product Overview
CST 301
CST 301 Product Overview
CytoSorb
CytoSorb Product Overview
CytoSorb Clinical Trial
CytoSorb-XL
CytoSorb-XL Product Overview
DrugSorb
DrugSorb Product Overview
HemoDefend
HemoDefend Product Overview
K+ontrol
K+ontrol Product Overview
CytoSorbents Corp-Key Competitors
CytoSorbents Corp-Key Employees
CytoSorbents Corp-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
CytoSorbents Corp, Recent Developments
Aug 13, 2019: CytoSorbents expands CytoSorb distribution in Latin America to Brazil, Colombia, and Costa Rica
Aug 06, 2019: CytoSorbents reports record second quarter 2019 financial results
Aug 05, 2019: CytoSorbents announces amendment to loan agreement with Bridge Bank, receives an additional USD 5 million cash from new term loan
May 07, 2019: CytoSorbents annopunces first quarter 2019 financial results
Apr 24, 2019: CytoSorbents Highlights the 6th International CytoSorb Users' Meeting and Recent Activities at the 2019 ISICEM and EuroELSO Conferences
Mar 25, 2019: Israel approves CytoSorb registration, CytoSorbents announces Gad Medical as distributor
Mar 07, 2019: CytoSorbents achieves record revenue and product sales growth in 2018
Mar 05, 2019: CytoSorbents expands direct sales to Poland, the Nordics, and the Netherlands
Feb 05, 2019: CytoSorbents to present at the 21st Annual BIO CEO & Investor Conference
Feb 04, 2019: CytoSorbents announces the Data Safety Monitoring Board recommends continuation of REMOVE Endocarditis Trial
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
CytoSorbents Corp Pipeline Products by Equipment Type
CytoSorbents Corp Pipeline Products by Development Stage
CytoSorbents Corp Ongoing Clinical Trials by Trial Status
List of Table
List of Tables
CytoSorbents Corp Pipeline Products and Ongoing Clinical Trials Overview
CytoSorbents Corp Pipeline Products by Equipment Type
CytoSorbents Corp Pipeline Products by Indication
CytoSorbents Corp Ongoing Clinical Trials by Trial Status
CytoSorbents Corp, Key Facts
CytoSorbents Corp, Major Products and Services
CytoSorbents Corp Number of Pipeline Products by Development Stage
CytoSorbents Corp Pipeline Products Summary by Development Stage
CytoSorbents Corp Ongoing Clinical Trials by Trial Status
CytoSorbents Corp Ongoing Clinical Trials Summary
BetaSorb-Product Status
BetaSorb-Product Description
ContrastSorb-Product Status
ContrastSorb-Product Description
CST 301-Product Status
CST 301-Product Description
CytoSorb-Product Status
CytoSorb-Product Description
CytoSorb-Case-observation and Compassionate Use: Use of Extracorporeal Treatment with the Cytosorb-adsorber for the Reduction of Postoperative Hyperinflammation and SIRS After Heart-surgery with the Use of a Heart-lung-machine
CytoSorb-Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation
CytoSorb-Cytokine Adsorption in Sepsis and Acute Kidney Injury
CytoSorb-CytoSorb Reduction of Freee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)
CytoSorb-Effectivity of Extracorporeal Cytokine Adsorption (Cytosorb) as Additive Treatment of CAR-T Cell Associated Cytokine Release (CRS) Syndrome and Encephalopathy Syndrome (CRES)
CytoSorb-Elimination of Antibiotics During Combined Continuous Renal Replacement Therapy and Cytosorb Adsorptive Therapy in Patients with Sepsis and Acute Kidney Injury
CytoSorb-Evaluating a CytoSorb Score in Septic Shock-A Retrospective Multicenter Data Analysis
CytoSorb-Extracorporeal Elimination of Cytokines Following Abdominal-thoracic Esophagectomy-A Randomized Study : EXCESS
CytoSorb-Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients with Rhabdomyolysis
CytoSorb-HaemoAdsorption Nach Reanimation an ECMO
CytoSorb-Hemoadsorption with CytoSorb in Post-Cardiac Arrest Syndrome: a Pilot Study (The CATCH Trial: Post Cardiac Arrest Therapy with Cytosorb Hemoadsorption)
CytoSorb-Immunomodulatory Effect of Extracorporeal Cytokine Adsorption in Cardiac Surgery
CytoSorb-International Registry on the Use of the CytoSorb-Adsorber in ICU Patients
CytoSorb-Pancreatitis CytoSorbents (CytoSorb) Inflammatory Cytokine Removal: A Prospective Study
CytoSorb-Removal of Cytokine on Cardiopulmonary Bypass with CytoSorb Compared to on- and Off-pump Myocardial Revascularization
CytoSorb-Removal of Cytokines During Cardiac Surgery
CytoSorb-Removal of Cytokines in Patients Undergoing Cardiac Surgery with CPB (The REMOTE Study)
CytoSorb-Revealing Mechanisms and Investigating Efficacy of Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients with Infective Endocarditis-A Multicentric Randomized Controlled Group Sequential Trial
CytoSorb-The Impact of Pre-emptive Intraoperative Use of Extracorporeal Cytokine Adsorption during Orthotopic Heart Transplantation
CytoSorb-XL-Product Status
CytoSorb-XL-Product Description
DrugSorb-Product Status
DrugSorb-Product Description
HemoDefend-Product Status
HemoDefend-Product Description
K+ontrol-Product Status
K+ontrol-Product Description
CytoSorbents Corp, Key Employees
CytoSorbents Corp, Subsidiaries
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.